Pilot Study of a Telehealth-Supervised Precision Exercise Program for Adults with Stage II-III Non-Small Cell Lung Cancer Receiving Multimodal Therapy

What this Trial Is About

Researchers are evaluating the feasibility of a precision exercise program called the Precision Exercise Regimen for Cancer Care PERCC for patients with stage II and stage III Non-Small Cell Lung Cancer NSCLC who are undergoing multimodal therapy. This pilot study focuses on whether this exercise program can be successfully implemented through telehealth for lung cancer patients receiving treatments at the University of Utahs Huntsman Cancer Institute. The PERCC program is a home-based exercise intervention supervised virtually. Participants will start exercising at least two weeks before their first neoadjuvant treatment and continue until two months after surgery. The exercises include mobility activities, aerobic, and resistance training performed in various positions such as lying down, sitting, standing, and walking. Each week, participants will have one supervised exercise session via telehealth focusing on resistance exercises, while aerobic exercises will be done individually without supervision. Throughout the study, participants will be monitored from the pre-treatment visit until about two months post-surgery. Researchers will assess recruitment and retention feasibility as the primary outcome, and safety as a secondary outcome during this period. Participants will complete questionnaires and follow the exercise program as prescribed, enabling study staff to evaluate how well the program can be delivered and maintained in this patient population.

PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study